| Dr Robert L Holman, MD, FACC | |
|
101 N Putnam Ave, Pueblo, CO 81005-1344 | |
| (208) 610-6392 | |
| Not Available |
| Full Name | Dr Robert L Holman |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 101 N Putnam Ave, Pueblo, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225083587 | NPI | - | NPPES |
| 003738300 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | M-6477 (Idaho) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | DR.0050537 (Colorado) | Primary |
| Entity Name | Us Health Dept Of Health & Human Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972694602 PECOS PAC ID: 9638081623 Enrollment ID: O20031106000399 |
News Archive
Aetna announced third-quarter 2013 operating earnings of $561.8 million, an increase of 7 percent over the third quarter of 2012. Third-quarter operating earnings per share were $1.50 in 2013 and $1.55 in 2012.
Resverlogix Corp. today announces the "Mechanism of Action" (MoA) by which RVX-208 increases apolipoprotein A-I (ApoA-I) production.
Boston-based Veritas Genetics, a pioneer in accessible genetic screening for disease prevention and early detection, received its first European CE mark approval for the company's hereditary breast and ovarian cancer genetic screening test, myBRCA. Veritas introduced myBRCA, which sequences BRCA1 and BRCA2 genes using proprietary gene-targeting technology and Next Generation Sequencing, in North America in May 2015.
The combination of rising Medicare premiums and no annual cost-of-living adjustment (COLA) would reduce Social Security payments for about 23 million of the nation's seniors in 2011, according to The Senior Citizens League. This figure represents two-thirds of the 37 million seniors who receive Social Security benefits.
One of the top ten killers for men older than 55 is the target of Clemson University research that could lead to a new life-saving therapy and a better way of telling whether surgery is necessary.
› Verified 8 days ago
| Entity Name | Dhhs Ihs Colville Service Unit |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811091911 PECOS PAC ID: 0941302509 Enrollment ID: O20070228000304 |
News Archive
Aetna announced third-quarter 2013 operating earnings of $561.8 million, an increase of 7 percent over the third quarter of 2012. Third-quarter operating earnings per share were $1.50 in 2013 and $1.55 in 2012.
Resverlogix Corp. today announces the "Mechanism of Action" (MoA) by which RVX-208 increases apolipoprotein A-I (ApoA-I) production.
Boston-based Veritas Genetics, a pioneer in accessible genetic screening for disease prevention and early detection, received its first European CE mark approval for the company's hereditary breast and ovarian cancer genetic screening test, myBRCA. Veritas introduced myBRCA, which sequences BRCA1 and BRCA2 genes using proprietary gene-targeting technology and Next Generation Sequencing, in North America in May 2015.
The combination of rising Medicare premiums and no annual cost-of-living adjustment (COLA) would reduce Social Security payments for about 23 million of the nation's seniors in 2011, according to The Senior Citizens League. This figure represents two-thirds of the 37 million seniors who receive Social Security benefits.
One of the top ten killers for men older than 55 is the target of Clemson University research that could lead to a new life-saving therapy and a better way of telling whether surgery is necessary.
› Verified 8 days ago
| Entity Name | Omak Tribal Health Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639210370 PECOS PAC ID: 1557458510 Enrollment ID: O20071107000666 |
News Archive
Aetna announced third-quarter 2013 operating earnings of $561.8 million, an increase of 7 percent over the third quarter of 2012. Third-quarter operating earnings per share were $1.50 in 2013 and $1.55 in 2012.
Resverlogix Corp. today announces the "Mechanism of Action" (MoA) by which RVX-208 increases apolipoprotein A-I (ApoA-I) production.
Boston-based Veritas Genetics, a pioneer in accessible genetic screening for disease prevention and early detection, received its first European CE mark approval for the company's hereditary breast and ovarian cancer genetic screening test, myBRCA. Veritas introduced myBRCA, which sequences BRCA1 and BRCA2 genes using proprietary gene-targeting technology and Next Generation Sequencing, in North America in May 2015.
The combination of rising Medicare premiums and no annual cost-of-living adjustment (COLA) would reduce Social Security payments for about 23 million of the nation's seniors in 2011, according to The Senior Citizens League. This figure represents two-thirds of the 37 million seniors who receive Social Security benefits.
One of the top ten killers for men older than 55 is the target of Clemson University research that could lead to a new life-saving therapy and a better way of telling whether surgery is necessary.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert L Holman, MD, FACC 101 N Putnam Ave, Pueblo, CO 81005-1344 Ph: (208) 610-6392 | Dr Robert L Holman, MD, FACC 101 N Putnam Ave, Pueblo, CO 81005-1344 Ph: (208) 610-6392 |
News Archive
Aetna announced third-quarter 2013 operating earnings of $561.8 million, an increase of 7 percent over the third quarter of 2012. Third-quarter operating earnings per share were $1.50 in 2013 and $1.55 in 2012.
Resverlogix Corp. today announces the "Mechanism of Action" (MoA) by which RVX-208 increases apolipoprotein A-I (ApoA-I) production.
Boston-based Veritas Genetics, a pioneer in accessible genetic screening for disease prevention and early detection, received its first European CE mark approval for the company's hereditary breast and ovarian cancer genetic screening test, myBRCA. Veritas introduced myBRCA, which sequences BRCA1 and BRCA2 genes using proprietary gene-targeting technology and Next Generation Sequencing, in North America in May 2015.
The combination of rising Medicare premiums and no annual cost-of-living adjustment (COLA) would reduce Social Security payments for about 23 million of the nation's seniors in 2011, according to The Senior Citizens League. This figure represents two-thirds of the 37 million seniors who receive Social Security benefits.
One of the top ten killers for men older than 55 is the target of Clemson University research that could lead to a new life-saving therapy and a better way of telling whether surgery is necessary.
› Verified 8 days ago
Dr. Christopher John Calcagno, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 N. Grand Ave., Ste. 300, Pueblo, CO 81003 Phone: 719-562-2001 Fax: 719-562-2742 | |
Christopher Jon Stark, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 400 W 16th St, Pueblo, CO 81003 Phone: 719-595-2218 Fax: 719-595-7994 | |
Greg Alan Bowman, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1600 N Grand Ave, Suite 500, Pueblo, CO 81003 Phone: 719-545-0663 Fax: 719-595-7903 | |
Lauren E. Sullenberger, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 902 Lakeview Ave, Pueblo, CO 81004 Phone: 719-557-5855 Fax: 719-557-5097 | |
Peter Lochow, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3670 Parker Blvd Ste 101, Pueblo, CO 81008 Phone: 719-564-1544 Fax: 719-924-1593 | |
Dr. Raj Vashistha, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3670 Parker Blvd., Ste 101, Pueblo, CO 81008 Phone: 719-564-1544 Fax: 719-924-1592 | |
Dr. Rebecca Elizabeth Holder, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1207 Pueblo Boulevard Way, Pueblo, CO 81005 Phone: 719-542-0032 Fax: 719-553-1904 |